Addiction

Ibogaine by David Dardashti Introduces New Algorithm for Methadone AddictionIbogaine by David Dardashti Introduces New Algorithm for Methadone Addiction

Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction

Algorithm Varies Slightly from Suboxone and Focuses on Continuously Dosed Ibogaine Treatment Methadone algorithm Ibogaine by David Dardashti is improving…

1 year ago
Ibogaine By David Dardashti Introduces New Algorithm for Depression TreatmentIbogaine By David Dardashti Introduces New Algorithm for Depression Treatment

Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment

A Revolutionary Advancement in Depression Treatments Ibogaine by David Dardashti A new algorithm to help combat depression MIAMI, April 21,…

1 year ago
Mobilize Recovery Cross-Country Bus Tour Galvanizes Community, Prevents OverdosesMobilize Recovery Cross-Country Bus Tour Galvanizes Community, Prevents Overdoses

Mobilize Recovery Cross-Country Bus Tour Galvanizes Community, Prevents Overdoses

Fifteen cities to host events in partnership with iHeartMedia, Meta, SAMHSA, Inseparable, and dozens of community partners coinciding with nationwide…

1 year ago
Revolutionizing Pain Management in Urgent Care CentersRevolutionizing Pain Management in Urgent Care Centers

Revolutionizing Pain Management in Urgent Care Centers

United Pain Urgent Care is Pioneering Non-Opioid Solutions for Acute Pain RENO, NV / ACCESSWIRE / April 17, 2023 /…

1 year ago
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement RatesBrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates

Company Announces 11th Recent System Installed in Israel, with More Expected this YearBURLINGTON, Mass. and JERUSALEM, April 17, 2024 (GLOBE…

1 year ago
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental DisordersClearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders

Tel Aviv, Israel / Vancouver, Canada, April 17, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”…

1 year ago
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacologyatai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally.BPL-003 was shown to be safe…

1 year ago
Awakn Life Sciences Announces Closing of Tranche of Private PlacementAwakn Life Sciences Announces Closing of Tranche of Private Placement

Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

1 year ago
Chromocell Issues Letter to Stockholders from Chief Executive OfficerChromocell Issues Letter to Stockholders from Chief Executive Officer

Chromocell Issues Letter to Stockholders from Chief Executive Officer

FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer…

1 year ago